Business
Accelerated bookbuild to raise up to £20m
Accelerated bookbuild to raise up to £20m.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0748D\n Angle PLC\n 24 June 2021\n \n \n \n \n THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN (TOGETHER, THIS \"ANNOUNCEMENT\") IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL (\"RESTRICTED JURISDICTION\"). THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES. THE SECURITIES DISCUSSED HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE \"US SECURITIES ACT\") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT. NO PUBLIC OFFERING OF THE SECURITIES DISCUSSED HEREIN IS BEING MADE IN THE UNITED STATES AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFERING OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR THE REPUBLIC OF IRELAND.\n \n \n \n \n \n \n \n \n FURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN ANGLE PLC IN ANY JURISDICTION IN WHICH ANY SUCH, OFFER OR SOLICITATION WOULD BE UNLAWFUL.\n \n \n \n \n \n 24 June 2021\n \n \n \n \n \n ANGLE plc \n \n \n (\"ANGLE\" or the \"Company\")\n \n \n \n \n \n Accelerated bookbuild to raise gross proceeds of up to £20 million\n \n \n \n \n \n ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, today announces a Placing to raise gross proceeds of up to £20 million at a price of 116 pence (the \"Issue Price\") per new ordinary share of 10 pence each in the capital of the Company (\"New Ordinary Shares\") (the \"Placing\"), through finnCap and WG Partners, acting as joint brokers to the Company alongside Beech Hill Securities (\"BeechHill\") who are acting as US broker to the Company.\n \n \n \n \n \n \n \n \n Placing highlights:\n \n \n \n · \n Placing to raise gross proceeds of up to £20 million at a price of 116 pence per New Ordinary Share...